Radon on the RADAR (Residents Acting to Detect and Alleviate Radon) 2.0

September 4, 2026 updated by: Stacy Stanifer
This study will test the effects of radon risk messages with different target groups on intention to test/mitigate.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

500

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Rural resident participants must be a homeowner or the primary decision maker in the home.
  • Rural resident participants must live in a rural area, defined as residence in a rural-urban community area (RUCA) with a code of 4-7.
  • Rural resident participants must be able to read and speak english.
  • Participants in the radon messaging groups will include individuals who have never tested their home for radon and individuals whose home has tested high for radon but have not mitigated their home.

Exclusion Criteria:

  • For rural resident online study, individuals who are not a homeowner or primary decision maker in the home, do not live in a qualifying rural area, or do not have internet access.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Treatment Group
Newly designed or adapted radon risk messaging materials.
Behavioral: Radon Risk Messaging Materials
Newly designed or adapted radon risk messaging materials intended to increase radon awareness and risk perception or prompt radon mitigation.
Active Comparator: Comparison Group
Generic or standard radon materials from the Environmental Protection Agency (EPA) or Centers for Disease Control (CDC).
Behavioral: Radon Risk Messaging Materials
Newly designed or adapted radon risk messaging materials intended to increase radon awareness and risk perception or prompt radon mitigation.
No Intervention: Waitlist Control
No radon messaging materials during the trial. Participants may receive information about radon after the trial.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intention to Test or Mitigate for Radon
Time Frame: Immediately after viewing the messages
Participants' intention to test for radon or take steps to mitigate radon, assessed by asking how soon the participants plan to test for radon or take steps to fix radon.
Immediately after viewing the messages

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Stacy Stanifer

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

October 1, 2026

Primary Completion (Estimated)

April 1, 2027

Study Completion (Estimated)

May 31, 2029

Study Registration Dates

First Submitted

August 28, 2026

First Submitted That Met QC Criteria

August 28, 2026

First Posted (Actual)

September 8, 2026

Study Record Updates

Last Update Posted (Actual)

September 10, 2026

Last Update Submitted That Met QC Criteria

September 4, 2026

Last Verified

August 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 97187

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe